I’ve spent the better part of this week fielding the same question from a couple of friends who rarely talk markets: “How do I get in on Anthropic without waiting for the IPO?” It is a fair ask. When a frontier AI lab is reportedly eyeing a valuation between $1.5 trillion and $2 trillion, the noise gets loud fast. People who sat out the last couple of mega-listings are suddenly scanning for any way to own a slice of the story before the ticker appears. That search has already pushed certain corners of the market higher, and it raises a practical question for anyone trying to stay disciplined: which related names actually make sense as exposure, and which ones are just riding the wave of the moment?
Why Proxies Matter More Than the Listing Itself Right Now
Waiting for the actual public debut can feel like standing in a long queue while the party is already happening inside. Market participants have been positioning for weeks, and the filing simply accelerated what was already in motion. Semiconductors bounced, memory names jumped, and cybersecurity names found a bid. That pattern is familiar. Large private AI companies do not exist in isolation; their compute needs, partnerships, and capital plans create demand across an entire supply chain. Owning a piece of that chain can be a way to participate without needing an allocation in the IPO itself.
Of course, history is littered with IPOs that looked unstoppable on day one and then spent the next twelve months grinding lower. Recent large listings have reminded everyone that the first year can be brutal. One high-profile example closed well above its offer price in the days after trading began, only to give back a sizable chunk of those gains. The same risk applies here. A $1.5 trillion to $2 trillion valuation leaves little room for disappointment on growth or margins. Still, the near-term bid in related stocks is real, and it is worth understanding where it is coming from.
Semiconductor and Memory Names Already Reflecting Higher Demand
Chipmakers sit at the center of any serious AI build-out. One name in particular has drawn repeated attention from analysts as a direct beneficiary. It is a major partner for the infrastructure Anthropic needs, and this week it disclosed that a special-purpose vehicle will finance $63 billion in chips and networking products to be leased to the company. Earlier, Anthropic itself said the same chipmaker had agreed to lend it up to $42 billion for AI infrastructure. Those are not small numbers, and they help explain why the stock is up roughly 8 percent for the week.
Memory has been even more dramatic. The round of optimism lifted a dedicated memory ETF by 13 percent week to date. When training and inference workloads scale, both high-bandwidth memory and more conventional DRAM see increased pull-through. I’ve found that these moves can overshoot in the short run, yet the underlying demand picture is hard to dismiss while frontier labs continue to raise capital and sign multi-year supply agreements. The semiconductor ETF itself gained 8 percent over the same stretch, a reminder that the rally is broader than any single name.
Traders have been anticipating this. All of these AI fears, and rumors, concerns will be abated for now.
– Market strategist
That comment captures the current mood. Concerns about capital intensity or competition have not vanished, but they have been pushed to the side while the market focuses on the next large public AI story. Whether that relief lasts depends on how smoothly the listing process unfolds and what the company ultimately discloses about its path to profitability.
Neocloud Operators Positioned for Training and Inference Growth
Another group drawing interest is the specialized cloud providers that sell compute capacity to AI labs and enterprises. Analysts at one firm noted significant opportunity ahead because rising safety requirements and the shift toward agentic systems will require more training and inference compute. Two publicly traded names in that category have already responded: one is up almost 12 percent for the week, the other more than 8 percent. These companies are not household names for most retail investors, yet they sit closer to the actual workload than many traditional cloud giants.
The thesis is straightforward. If Anthropic continues to expand its model training runs and its customer base, someone has to supply the GPUs, the power, and the data-center space. Neoclouds have built their businesses around exactly that demand. They also tend to be more flexible on contract terms than the largest hyperscalers, which can matter when a lab is scaling quickly and wants dedicated capacity. Of course, that flexibility comes with concentration risk. A slowdown in spending by one or two large customers can show up quickly in the financials. That is the trade-off investors are weighing.
Direct Ownership Through the Large Technology Partners
Two of the biggest technology platforms have already written large checks. In April one agreed to invest up to $25 billion. The same month the other said it planned to invest up to $40 billion, expanding a partnership that had already been in place for some time. Those stakes give both companies economic exposure to Anthropic’s success even if the AI lab remains private for a while longer. When the IPO eventually happens, those holdings can be marked higher or, in some cases, partially monetized.
From an investor’s perspective, buying the parent companies is the most straightforward proxy available in public markets today. You get the Anthropic upside plus the rest of each company’s diversified businesses. The downside is dilution of the pure AI theme. If Anthropic’s valuation soars but the parent’s other segments lag, the stock may not fully reflect the private stake. Still, for many portfolios these names are already core holdings, so the additional exposure arrives with little incremental effort.
Perhaps the most interesting aspect is how these investments were structured. They are not simple equity checks; they often come with cloud-commitment agreements that lock in future spending. That dual nature means the benefit flows both ways: Anthropic gets capital and guaranteed compute, while the investor gets both equity upside and incremental cloud revenue. It is a structure that has become common in the current AI funding cycle, and it is worth watching how it evolves once Anthropic is public and subject to quarterly reporting.
Funds and ETFs That Already Hold Exposure
Not every investor wants to pick individual stocks. Some prefer to own a fund that already has a position. One large-cap growth mutual fund with more than $350 billion in assets reported holdings in Anthropic valued at roughly $6.35 billion as of the end of August, across both common and preferred securities. Year to date the fund is up more than 8 percent. Its adjusted expense ratio sits at 0.59 percent, which is reasonable for an actively managed vehicle of that size.
On the ETF side, a large-cap blended fund with roughly $8 billion in assets disclosed that it acquired a stake in May valued at $54 million. That vehicle also holds the two large technology partners and a leading chip designer among its top positions. Its adjusted expense ratio is 0.31 percent. Owning either of these vehicles gives diversified exposure that includes Anthropic without requiring a separate brokerage account for private shares or waiting for the IPO allocation process.
| Vehicle Type | Approximate Anthropic Exposure | Expense Ratio | Recent Performance Note |
| Large-cap growth mutual fund | $6.35 billion (as of Aug 31) | 0.59% | More than 8% year to date |
| Large-cap blended ETF | $54 million (acquired in May) | 0.31% | Holds major AI partners in top weights |
| Semiconductor ETF | Indirect via chip suppliers | Varies | Up 8% this week |
| Memory ETF | Indirect via memory demand | Varies | Up 13% week to date |
The table is not exhaustive, and holdings can change. Still, it illustrates that both active managers and passive vehicles have already found ways to participate. For investors who prefer not to concentrate in a single name, these options reduce the need to time the IPO itself.
Cybersecurity and Broader Software Beneficiaries
The rally has not been limited to chips and cloud. A cybersecurity and technology ETF rose 3 percent this week. As AI systems become more capable and more widely deployed, the attack surface expands. Companies that sell tools for securing models, monitoring agent behavior, or protecting the data used in training can see incremental demand. It is an indirect link, and it will not move as violently as a pure-play chip supplier, yet it is part of the same narrative.
In my experience, these secondary beneficiaries often lag the initial spike and then catch up once the primary theme has been digested. They can also be less volatile on the way down if sentiment turns. That makes them worth a look for investors who want AI-adjacent exposure without the full amplitude of the semiconductor complex.
- Semiconductor and networking suppliers benefit from multi-year infrastructure commitments
- Specialized cloud providers capture incremental training and inference workloads
- Large platform companies already hold equity stakes and related cloud contracts
- Growth funds and ETFs provide diversified access without single-name risk
- Cybersecurity names see secondary demand as AI deployment widens the threat landscape
Each of those categories has its own risk profile. Concentration in one or two customers, high capital intensity, and valuation multiples that already embed aggressive growth assumptions are common themes. Understanding those differences is more useful than simply buying every name that moved higher this week.
The Crowding Risk and What History Suggests
A listing of this size does not enter a vacuum. It has to absorb capital that might otherwise have gone into existing public companies. One well-known market commentator warned this week that the sheer scale could put strain on an already crowded tape and potentially interrupt the broader rally. That concern is not abstract. When a single name is expected to raise tens of billions, portfolio managers have to decide what to sell or reduce in order to make room. Sometimes those sales hit the very stocks that had been bid up in anticipation.
Looking back at large technology IPOs over the past fifteen years, many of them underperformed in their first year. Severe drawdowns were common even for companies that later became successful. The pattern does not guarantee the same outcome here, but it does argue for sizing any new position with the possibility of a post-listing digestion period in mind. Space is limited in institutional portfolios, and the largest deals force rebalancing that can create temporary pressure.
I’ve found that the most durable gains in these situations tend to accrue to companies whose fundamentals improve independently of the IPO hype. If Anthropic’s spending plans materialize and continue for multiple years, the suppliers and partners that execute well should still benefit even if the stock of the newly public company itself trades sideways or lower for a period. That distinction between narrative and cash-flow impact is worth keeping front of mind.
Practical Considerations for Positioning
None of this is a recommendation to buy or sell any particular security. Markets can reverse quickly when expectations are this elevated. A few practical points have helped me think through similar situations in the past.
- Separate the near-term sentiment move from the multi-year demand outlook. The former can reverse; the latter is what ultimately matters for earnings.
- Check concentration. A neocloud or a specialized supplier may derive a large percentage of revenue from a handful of AI labs. That can be powerful on the way up and painful on the way down.
- Watch the parent companies’ cloud segments. Incremental revenue from Anthropic commitments should eventually appear in the numbers; if it does not, the equity stake alone may not be enough to move the needle.
- Size positions so that a 20 or 30 percent drawdown in the related names does not force an uncomfortable decision. First-year IPO volatility has a habit of spilling into the ecosystem.
- Revisit the thesis after the S-1 details are fully digested. Filings often contain more conservative guidance than the pre-listing rumors, and that gap can reset expectations.
These steps will not eliminate risk, but they can keep the exposure aligned with an investor’s actual time horizon and risk tolerance. The current enthusiasm is understandable. Frontier AI labs are rare, and the capital markets have shown they are willing to assign enormous valuations when growth appears unlimited. At the same time, the supply chain that supports those labs is already public and already pricing in a good deal of optimism.
Broader Context: Capital Intensity and the Path to Scale
One under-appreciated element of the current AI cycle is just how capital-intensive the leading models have become. Training runs that once cost tens of millions now run into the hundreds of millions or more, and the inference costs for serving millions of users add another ongoing layer. Anthropic’s reported fundraising and infrastructure commitments fit that pattern. The $42 billion lending agreement and the $63 billion special-purpose vehicle are concrete expressions of that intensity. They also create a multi-year revenue visibility for the suppliers involved, which is why those stocks have reacted.
Yet capital intensity cuts both ways. It raises the barrier to entry for new competitors, which can be positive for the incumbents, but it also means that any slowdown in customer willingness to pay, or any breakthrough that dramatically lowers compute requirements, can pressure the entire chain. Investors who treat the current spending plans as locked in forever may be surprised if efficiency gains arrive faster than expected. That possibility is not the base case for most analysts right now, but it belongs in the range of outcomes.
Another angle worth considering is the role of sovereign and enterprise demand outside the pure frontier labs. If Anthropic’s models prove useful for regulated industries or for government workloads, the addressable market expands beyond the current set of large technology customers. That expansion would support both the company itself and the infrastructure providers. Conversely, if adoption remains concentrated among a few well-funded labs, the growth trajectory could be lumpier than the market currently assumes. The S-1 will likely shed light on customer concentration and on the mix between training and inference revenue; those details will matter more than the headline valuation.
Comparing This Cycle to Earlier Technology Transitions
Every major platform shift has produced a set of public-market winners that were not the platform company itself. During the rise of mobile, component suppliers and certain software names outperformed for stretches even while the device makers captured the headlines. Cloud infrastructure followed a similar pattern: the hyperscalers grew enormously, yet specialized networking, storage, and security companies also created substantial shareholder value. The current AI build-out shares some of those characteristics. The difference is the speed and the absolute dollars involved.
What feels distinct this time is the degree to which private capital has already flowed into the leading labs before any public listing. That pre-IPO capital has allowed Anthropic and its peers to sign large, multi-year commitments with suppliers. Those commitments are now visible in the order books and the guidance of public companies, which is why the stocks have moved ahead of the listing. In earlier cycles, much of that demand only became visible after the platform company was already public and reporting quarterly. The compressed timeline changes the rhythm of the trade.
Still, the endgame remains similar. Eventually the market will want to see that the massive capital expenditures translate into durable free cash flow, either at the lab level or at the supplier level. Until that evidence appears, valuations can stay elevated on narrative alone, but they remain vulnerable to any data point that suggests the spending cycle is peaking. Keeping an eye on utilization rates at the neoclouds, on memory pricing trends, and on the cloud revenue growth rates at the large platforms can provide earlier signals than waiting for Anthropic’s own filings.
Sentiment Versus Substance in the Current Tape
The week’s price action has been dominated by positioning rather than by new fundamental disclosures. The S-1 filing itself is what traders had been waiting for; once it arrived, the relief rally was almost mechanical. That does not make the moves illegitimate, but it does mean they can reverse just as mechanically if the next data point disappoints. I’ve watched similar setups play out around other high-profile listings. The initial pop often fades once the calendar fills with earnings reports and macro releases that have nothing to do with the new issue.
One useful habit is to separate the names whose earnings estimates have actually been revised higher from those that have simply risen on multiple expansion. The former group has a cushion if sentiment cools. The latter group can give back gains quickly. At the moment, several semiconductor and networking suppliers have seen upward revisions tied to the infrastructure announcements. That is more constructive than a pure multiple re-rating. Memory names are more mixed; some of the move reflects tighter supply-demand balances that pre-date the Anthropic headlines, while the rest is incremental optimism.
For the large platform companies, the Anthropic stakes are still small relative to overall market capitalization. A substantial mark-up in those private holdings would be noticeable, yet it would not redefine the investment case on its own. Investors who already own those stocks for their cloud, advertising, or consumer franchises are simply getting an additional call option. That option has value, but it should not be the sole reason for holding the position.
What to Watch After the Initial Excitement Fades
Once the filing is fully absorbed and the roadshow begins, attention will shift to the details that were not in the early headlines. Customer concentration, the split between training and inference revenue, the expected timeline for positive free cash flow, and any commentary on competitive dynamics will all matter. Any indication that Anthropic expects to moderate its infrastructure spending in the near term would likely pressure the supplier names that have rallied on the assumption of continued acceleration.
Power availability and data-center construction timelines are another practical constraint. Even if the capital is committed, physical capacity has to be built and energized. Delays in those areas have already affected other large AI projects. If similar bottlenecks appear in Anthropic’s plans, the revenue recognition for chip and networking suppliers could be pushed out, even if the long-term agreements remain intact. Those timing issues rarely show up in the initial valuation discussions, yet they can affect quarterly results for the public companies involved.
Finally, the broader rate and liquidity environment will still set the backdrop. A listing of this magnitude absorbs a meaningful amount of risk capital. If financial conditions tighten for unrelated reasons, the appetite for high-multiple AI exposure can diminish quickly. That is not a forecast, merely a reminder that the Anthropic story does not exist in isolation. The same investors who are currently eager for proxies will also be managing duration risk, credit spreads, and equity-market volatility from other sources.
Building a Measured Approach Rather Than Chasing the Tape
The desire to participate is understandable. Missing a generational technology shift is a real opportunity cost, and the proxies currently available in public markets offer a way to express a view without waiting for an uncertain IPO allocation. At the same time, the valuations already embed a substantial amount of success. Adding exposure at these levels requires a clear view on how much additional upside remains once the listing is complete and the initial enthusiasm normalizes.
One approach that has worked for some investors in prior cycles is to identify the suppliers whose order books and capacity plans already reflect the new demand, then to add gradually rather than all at once. That reduces the risk of buying the entire position on the day of maximum excitement. It also leaves room to increase the stake if subsequent filings or earnings reports confirm that the spending is translating into revenue at the expected pace. Patience is not always rewarded in momentum-driven markets, yet it has a better track record once the initial re-rating is finished.
Diversification across the different layers of the stack can also help. A combination of a semiconductor supplier, a specialized cloud provider, and one of the large platform companies spreads the specific risks while still keeping the portfolio tied to the broader AI infrastructure theme. Adding a cybersecurity name provides a further offset if the pure compute names become too extended. None of these choices eliminates the possibility of a broad de-rating, but they do reduce reliance on any single point of failure.
The market can ride that wave of optimism for some time, yet the first year after a large listing has often been unforgiving.
That tension between near-term momentum and longer-term fundamental delivery is the central tension right now. Investors who can hold both ideas at once are better positioned than those who treat the current rally as either permanent or meaningless. The proxies exist, the demand signals are tangible, and the historical cautionary tales are equally real. Sorting through those elements with a clear time horizon is more useful than trying to guess the exact opening price of a company that is not yet public.
Longer-Term Questions the Market Will Eventually Have to Answer
Beyond the immediate positioning, a few structural questions will shape returns over a multi-year horizon. How quickly can inference costs fall, and will that reduction expand the total addressable market faster than it compresses revenue per unit of compute? Will enterprise adoption of agentic systems create a second wave of demand that is less dependent on a handful of frontier labs? And how will regulators treat the largest model providers once they are public companies subject to disclosure and, potentially, to new rules around safety and competition?
Answers to those questions will not arrive with the first earnings report. They will emerge gradually through customer wins, through pricing trends in the cloud market, and through the competitive responses of other well-funded labs. In the meantime, the public companies that supply the picks and shovels will continue to report their own results. Those reports will offer the most frequent and most verifiable data points available to investors who want exposure to the theme without owning the private or newly public lab itself.
For now, the tape is reflecting relief and anticipation more than settled conclusions. That is normal at this stage of a large listing process. The work for anyone considering the proxies is to decide how much of the anticipated success is already in the price, how much additional evidence they need before increasing exposure, and how they will respond if the post-listing period proves as volatile as many earlier examples. Those decisions are individual, but they are easier to make when the range of outcomes is kept in view rather than collapsed into a single optimistic narrative.
The friends who asked me about getting in early are still deciding. Some will buy a broad semiconductor fund and call it a day. Others will dig into the neocloud financials and accept the concentration risk. A few will simply add to the large platform companies they already own and treat the Anthropic stake as a free option. All of those choices can be reasonable depending on the rest of the portfolio and on the investor’s ability to sit through the inevitable swings. What none of them require is perfect foresight about the opening day of trading. The infrastructure build-out is already underway, and the public market has already begun to price pieces of it. The rest is a question of sizing, timing, and patience.
